top of page

KRAS Cancer News & Updates



Getting ahold of KRAS Science: Visiting Kevan Shokat at his UCSF Lab
By the time I met Kevan Shokat, KRAS G12D was already the name of the devil my body was fighting.
Then Kevan did something extraordinary. He made me a three dimensional model of KRAS, had it painted, and sent it to me with a handwritten letter.

Terri Conneran KRAS Kickers
Sep 28


How KRAS Became Druggable: Kevan Shokat and the Pocket That Opened a New Era of RAS Drugs
more than 60 additional drugs targeting the RAS family are now in development. What began with a chemical foothold in KRAS G12C has become an expanding field of RAS drug discovery. Why This Matters for People With KRAS Cancer The science also explains why knowing the exact KRAS variant matters.

Terri Conneran KRAS Kickers
Sep 28


Precision Medicine has Empowered Cancer Patients
One of the patient voices from this documentary is Terri Conneran: Empowering the Patients For Precision Cancer Advocacy In the documentary, powerful stories from patients, industry experts, and healthcare providers about how precision medicine has empowered their healthcare decisions, providing renewed hope .

Terri Conneran KRAS Kickers
Jun 5, 2025


Unveiling impacts: A quality of life survey for individuals with a history or diagnosis of cancer.
https://ascopubs.org/doi/abs/10.1200/JCO.2024.42.16_suppl.e23179 Abstract Journal of Clinical Oncology Volume 42, Number 16_suppl June 2024 e23179 Background: Cancer treatments, despite increasing effectiveness, involve significant short and long-term side effects profoundly impacting a person's quality of life (QoL). In response, Advocates for Collaborative Education, a global coalition of patient advocates, initiated an exempt, online survey to gather insights on the percei

Terri Conneran KRAS Kickers
Apr 25, 2025


Essential Guide to Cancer Biomarkers For Cancer Patients
Need to know what mutation is driving the cancer bus. It's different than noise from the back of the bus.
Biomarkers testing tells us what to Aim for as the cancer driver, not the background noise. Taking out the cancer driver can make the difference.
Biomarkers provide the insights as to what is driving the cancer.

Terri Conneran KRAS Kickers
Apr 22, 2025


KICKING KRAS LUNG CANCER!
Upstage Lung Cancer heard the power of hope to kick cancer from Terri Conneran

Terri Conneran KRAS Kickers
Dec 19, 2024
Creating an Advocacy Group at the Onset of a Global Pandemic: KRAS Kickers Founder Shares Her Story
December 29, 2022 https://www.curetoday.com/view/creating-an-advocacy-group-at-the-onset-of-a-global-pandemic-kras-kickers-founder-shares...
shannon8797
Jan 6, 2023


Terri's Journey to KRAS Kickers
Terri shares her stage 3A KRAS+ lung cancer story, including experiencing three separate recurrences. She persevered through multiple...

ThePatientStory
Apr 16, 2021
Terri Conneran’s Diagnosis Journey: Asthma or Lung Cancer
Like many other lung cancer patients, Terri Conneran’s road to diagnosis did not follow a direct route. For the entire summer leading up...

Terri Conneran KRAS Kickers
Mar 1, 2021
Kicking Cancer's __s!
Dusty Donaldson When Terri Conneran was first diagnosed with lung cancer, she focused on kicking cancer’s ass. That was before...

Terri Conneran KRAS Kickers
Mar 1, 2021
Overcoming Lung Cancer Stigma
Korin Miller She hid her diagnosis from her kids on Christmas Day: ' I didn’t want to ruin their Christmas' Terri Conneran had been...
Korin Miller
Dec 5, 2020
Getting ahold of KRAS Science: Visiting Kevan Shokat at his UCSF Lab
By the time I met Kevan Shokat, KRAS G12D was already the name of the devil my body was fighting.
Then Kevan did something extraordinary. He made me a three dimensional model of KRAS, had it painted, and sent it to me with a handwritten letter.
How KRAS Became Druggable: Kevan Shokat and the Pocket That Opened a New Era of RAS Drugs
more than 60 additional drugs targeting the RAS family are now in development. What began with a chemical foothold in KRAS G12C has become an expanding field of RAS drug discovery. Why This Matters for People With KRAS Cancer The science also explains why knowing the exact KRAS variant matters.
Where can patients find the NCCN guidelines used to guide cancer treatment?
NCCN Guidelines help clinicians determine what evaluations are appropriate, which treatment options are supported by current evidence, when additional testing may be important, and how care may change as a cancer changes.For patients, NCCN offers a version for patients.

bottom of page
